Intellia surges after Phase 1 results for CRISPR-based HAE treatment (NASDAQ:NTLA)
Thanakorn Piadaeng/iStock via Getty Images Following the release of encouraging long-term data from a Phase 1 trial of its CRISPR-based ...
Tag: NASDAQNTLA
Discover the latest in stocks, finance, cryptocurrency, and real estate with Fermat Ventures. Stay informed with expert analysis, timely updates, and comprehensive coverage of the financial markets.
